Elanco Animal Health (ELAN) Non-Current Assets (2017 - 2026)

Elanco Animal Health (ELAN) reported Non-Current Assets of $9.6 billion for Q1 2026, up 1.44% on a YoY basis from $9.5 billion in Q1 2025, and down 2.65% sequentially from $9.9 billion in Q4 2025.

Elanco Animal Health (ELAN) Non-Current Assets (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Non-Current Assets data on file, last reported at $9.6 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 1.44% year-over-year to $9.6 billion; the trailing twelve-month figure through Mar 2026 stood at $39.7 billion (up 2.99% YoY), and the FY2025 full-year result was $9.9 billion, up 5.33% from the prior year.
  • Non-Current Assets declined to $9.6 billion in Q1 2026, from $9.9 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $13.1 billion in Q1 2022 to a low of $9.4 billion in Q4 2024.
  • A 5-year average of $10.8 billion and a median of $10.1 billion in 2025 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets retreated 19.69% in 2024 and climbed 5.33% in 2025, its largest moves.
  • Tracing ELAN's Non-Current Assets over 5 years: stood at $12.2 billion in 2022, then decreased by 10.29% to $11.0 billion in 2023, then dropped by 14.2% to $9.4 billion in 2024, then grew by 5.33% to $9.9 billion in 2025, then slipped by 2.65% to $9.6 billion in 2026.
  • Business Quant data shows ELAN's Non-Current Assets at $9.6 billion in Q1 2026, $9.9 billion in Q4 2025, and $10.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 670.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.64 Bn
Dec 31, 2025 9.90 Bn
Sep 30, 2025 10.06 Bn
Jun 30, 2025 10.13 Bn
Mar 31, 2025 9.50 Bn
Dec 31, 2024 9.40 Bn
Sep 30, 2024 9.92 Bn
Jun 30, 2024 9.75 Bn
Mar 31, 2024 9.97 Bn
Dec 31, 2023 10.96 Bn
Sep 30, 2023 10.78 Bn
Jun 30, 2023 12.14 Bn
Mar 31, 2023 12.22 Bn
Dec 31, 2022 12.21 Bn
Sep 30, 2022 11.79 Bn
Jun 30, 2022 12.29 Bn
Mar 31, 2022 13.06 Bn
Dec 31, 2021 13.20 Bn
Sep 30, 2021 13.41 Bn
Jun 30, 2021 13.40 Bn